1 |
任成山,王关嵩,钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
2 |
陈华萍,甘志新,刘 刚,等. 慢性阻塞性肺疾病的合并症/并发症的发病率和病死率分析[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(4): 417-421.
|
3 |
徐 宁,宋鹏飞,段圆方,等. 慢性阻塞性肺疾病急性加重期外周血mir-146a、mir-223的表达[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(6): 757-759.
|
4 |
高 瞻,尹 燕,晏 妮,等. 慢性阻塞性肺疾病并发焦虑抑郁患者临床特征及风险评估[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(5): 625-629.
|
5 |
Cao FT, Cui Y, Mao J, et al. Application of non-invasive positive pressure ventilation combined with PetCO monitoring for patients with chronic obstructive pulmonary disease combined with severe respiratory failure[J]. J Coll Physicians Surg Pak, 2019, 29(6): 545-548.
|
6 |
Zhao DJ, Feng JF. Efficacy of low molecular weight heparin for chronic obstructive pulmonary disease and respiratory failure: A protocol of systematic review of randomized controlled trials[J]. Med, 2019, 98(48): e18051.
|
7 |
刘易其,李冬琼,陈明菊,等. 经鼻高流量湿化氧疗与无创正压通气治疗慢性阻塞性肺疾病急性加重期合并Ⅱ型呼吸衰竭患者疗效的研究[J]. 西南医科大学学报,2020, 43(4): 349-353.
|
8 |
Wilson ME, Dobler CC, Morrow AS, et al. Association of home noninvasive positive pressure ventilation with clinical outcomes in chronic obstructive pulmonary disease: A systematic review and Meta-analysis[J]. JAMA, 2020, 323(5): 455-465.
|
9 |
Wilson ME, Murad MH, Wang Z. Home noninvasive positive pressure ventilation for chronic obstructive pulmonary disease-reply[J]. JAMA, 2020, 323(23): 2432-2433.
|
10 |
慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版)[J]. 国际呼吸杂志,2017, 37(14): 1041-1057.
|
11 |
庞土富,易震南,陈祖光,等. 布地奈德福莫特罗粉吸入剂联合无创呼吸机治疗COPD合并Ⅱ型呼吸衰竭的疗效及其对氧合功能的影响[J]. 广东医科大学学报,2021, 39(2): 154-156.
|
12 |
Duiverman ML, Vonk JM, Bladder G, et al. Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial[J]. Thorax, 2020, 75(3): 244-252.
|
13 |
李承峰. BiPAP呼吸机治疗COPD合并Ⅱ型呼吸衰竭的效果以及对动脉血气指标的影响分析[J]. 中国现代药物应用,2021, 15(2): 24-26.
|
14 |
刘 琴. 无创正压通气NIPPV两种通气模式治疗COPD合并Ⅱ型呼吸衰竭患者的疗效及安全性分析[J]. 河北医学,2019, 25(4): 668-671.
|
15 |
车卫华. 布地奈德气雾剂联合BiPAP呼吸机治疗慢性阻塞性肺气肿合并Ⅱ型呼吸衰竭的效果[J]. 实用临床医学,2020, 21(6): 15-17.
|
16 |
李荣凯. 沙美特罗替卡松配合BIPAP呼吸机治疗慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭的临床观察[J]. 中国实用医刊,2020, 47(10): 76-78.
|
17 |
潘家华,刘 云,骆玉兔. BiPAP无创呼吸机治疗慢阻肺合并Ⅱ型呼吸衰竭临床效果分析[J]. 系统医学,2020, 5(19): 40-42.
|
18 |
杨慧亮,李 颖,巴晓彤. 时间控制通气模式对COPD合并Ⅱ型呼吸衰竭患者血气分析和呼吸力学指标的影响[J]. 临床和实验医学杂志,2020, 19(18): 37-40.
|
19 |
Souza A, Sperandio PA, Mazzuco A, et al. Effects of bi-level positive airway pressure on ventilatory and perceptual responses to exercise in comorbid heart failure-COPD.[J]. Respir Physiol Neurobiol, 2019, 2(66): 18-26.
|
20 |
Jayashankar JP, Rajan P, Kottayil BP, et al. Comparison of nasal Bi-level positive airway pressure versus high-flow nasal cannula as a means of noninvasive respiratory support in pediatric cardiac surgery[J]. Anesth Essays Res, 2020, 14(2): 283-287.
|